Grifols Shares Results From its Chronos Platform Identifying Early Molecular Changes Associated with Parkinson’s Disease
Grifols, S.A. - American Depositary Shares (GRFS)
Last grifols, s.a. - american depositary shares earnings: 5/7 07:27 am
Check Earnings Report
US:NASDAQ Investor Relations:
grifols.com/en/web/international/investor-relations/home-page
Company Research
Source: GlobeNewswire
Chronos-PD shows that biological changes associated with Parkinson’s disease (PD) can emerge up to 12 years before clinical diagnosisUncovered reproducible early molecular signals and distinct molecular patterns in PD, supporting future efforts in patient stratification and precision medicine researchChronos is part of a broad Grifols program to find early disease biomarkers leveraging more than 100 million proprietary plasma samples connected to real-world data on thousands of conditions Grifols presents data in 13 posters and oral presentations at AD/PD™ 2026 conference in Copenhagen (Denmark) BARCELONA, Spain, March 17, 2026 (GLOBE NEWSWIRE) -- Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company and leading producer of plasma-derived medicines, today shared proof-of-concept data from its Chronos-PD program, demonstrating that biological changes in individuals with Parkinson’s disease (PD) occur more than a decade before clinical diagnosis, with potential futur
Show less
Read more
Impact Snapshot
Event Time:
GRFS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GRFS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GRFS alerts
High impacting Grifols, S.A. - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
GRFS
News
- Grifols Shares Results From its Chronos Platform Identifying Early Molecular Changes Associated with Parkinson's Disease [Yahoo! Finance]Yahoo! Finance
- Grifols (GRFS) was downgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=GRFS&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "buy" to "hold"MarketBeat
- Grifols SA (GRFS) (Full Year 2025) Earnings Call Highlights: Strong Revenue Growth Amidst ... [Yahoo! Finance]Yahoo! Finance
- Grifols (NASDAQ:GRFS) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.MarketBeat
GRFS
Sec Filings
- 2/26/26 - Form 6-K
- 2/26/26 - Form 6-K
- 2/17/26 - Form SCHEDULE
- GRFS's page on the SEC website